(XHS) SPDR S&P Health Care - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US78464A5737 • Health
XHS: Hospitals, Medical, Facilities, Laboratories, Insurance, Pharmaceuticals
The SPDR® S&P Health Care Services ETF (NYSE ARCA:XHS) is designed to provide exposure to the health care services sector by tracking the performance of the S&P Health Care Services Select Industry Index. The fund employs a sampling strategy, typically investing at least 80% of its total assets in securities that comprise the index. This approach allows for efficient tracking of the indexs performance while maintaining liquidity. The index itself is a subset of the S&P Total Market Index (S&P TMI), focusing specifically on companies within the health care services segment. This includes entities involved in health care equipment, services, and distributors. For more information, visit: http://www.spdrs.com.
As an ETF, XHS offers investors a targeted way to gain exposure to the health care services industry. Its investment strategy involves replicating the holdings and weightings of the S&P Health Care Services Select Industry Index, ensuring that the funds portfolio aligns closely with the indexs composition. The funds assets under management (AUM) total $82.56 million, indicating a moderate size that balances accessibility with diversification. This structure allows XHS to serve as a tool for investors seeking to capitalize on the growth and stability of the health care services sector within the broader market.
Additional Sources for XHS ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
XHS ETF Overview
Market Cap in USD | 84m |
Category | Health |
TER | 0.35% |
IPO / Inception | 2011-09-28 |
XHS ETF Ratings
Growth Rating | 32.0 |
Fundamental | - |
Dividend Rating | 38.7 |
Rel. Strength | 3.21 |
Analysts | - |
Fair Price Momentum | 88.98 USD |
Fair Price DCF | - |
XHS Dividends
Dividend Yield 12m | 0.34% |
Yield on Cost 5y | 0.52% |
Annual Growth 5y | 8.64% |
Payout Consistency | 65.2% |
XHS Growth Ratios
Growth Correlation 3m | -56.1% |
Growth Correlation 12m | 62.6% |
Growth Correlation 5y | 6.1% |
CAGR 5y | 9.48% |
CAGR/Max DD 5y | 0.29 |
Sharpe Ratio 12m | 0.48 |
Alpha | 3.96 |
Beta | 1.050 |
Volatility | 23.48% |
Current Volume | 3.6k |
Average Volume 20d | 5.2k |
As of April 16, 2025, the stock is trading at USD 96.87 with a total of 3,589 shares traded.
Over the past week, the price has changed by +4.08%, over one month by -0.07%, over three months by +1.64% and over the past year by +11.40%.
Neither. Based on ValueRay Analyses, SPDR S&P Health Care is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 32.03 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XHS as of April 2025 is 88.98. This means that XHS is currently overvalued and has a potential downside of -8.14%.
SPDR S&P Health Care has no consensus analysts rating.
According to ValueRays Forecast Model, XHS SPDR S&P Health Care will be worth about 99.1 in April 2026. The stock is currently trading at 96.87. This means that the stock has a potential upside of +2.25%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 99.1 | 2.3% |